Angus C. Russell

Angus C. Russell is a declared insider at 6 companies (board member); the most frequent names are Mallinckrodt plc, Revance Therapeutics, Inc. and Intermune Inc. Over a trading history stretching from 31 October 2011 to 6 February 2025, the count stands at 52 filings.

On the open market, the record shows 10 purchases worth €824k and 2 sales worth €17k. On balance, insiders were net buyers of €807k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 30 share grants and 4 option exercises.

Half of the purchases are above €66k and half below. On 4 out of 4 purchases, another insider of the same company was buying within the same 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.

Most recently, on 6 February 2025, the filings show a transaction in Revance Therapeutics, Inc. The most recent open-market purchase was published on 15 December 2021, 1,774 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.